Strategic Advisory Group of Experts on Immunization (SAGE) - April 2017

25 – 27 April 2017

The SAGE meeting of 25-27 April 2017 was held in the Executive Board (EB) room at WHO HQ in Geneva. Available on this site you will find meeting information, background reading materials and presentations made at the meeting. The conclusions and recommendations of SAGE meeting are published in the WHO Weekly Epidemiological Record in English and French within two months of each SAGE meeting.

Meeting materials

Agenda
List of participants
Declaration of interest
SAGE report - conclusions and recommendations

 

Related

 

Background documents and presentations 

SAGE Yellow Book - April 2017

 

Session: Report from IVB director

Background documents

Meeting of the Strategic Advisory Group of Experts on immunization, October 2016 – conclusions and recommendations

Summary World Immunization Week 2017, 24-30 April 2017

SAGE tracking record of recommendations and action points

Report of the AFRO Regional Immunization Technical Advisory Group Meeting, 12-13 December 2016, Dakar, Senegal

Declaration on universal access to immunization as a cornerstone for health and development in Africa, Addis Ababa, 2016

Ad-hoc Virtual TAG Meeting 2017, XXV Meeting of the Technical Advisory Group on Vaccine-preventable Diseases, 10 March 2017 Washington, DC, USA

16th meeting of the European Technical Advisory Group of Experts on Immunization (ETAGE)

2016 progress report Immunization Demand team. Division of Health Emergencies and Communicable Diseases (DEC).Vaccine-preventable Diseases programme (VPI). WHO Regional Office for Europe

Fifth hepatitis B immunization experts resource panel consultation, 15–17 February 2017, Manila, Philippines

Presentations

Global report including key updates and challenges from regions - J.M. Okwo-Bele

Show less Show more

Session: Report from GAVI, the Vaccine Alliance

Session: Report from other advisory committees on immunization

Background documents

Global Advisory Committee on Vaccine Safety (GACVS), 30 November-01 December 2016. WER No 2, 2017, 92, 13–20

Immunization in Practices Advisory Committee (IPAC) Terms of reference (Draft 03.04.2017)

Guidelines on regulatory preparedness for provision of marketing authorization of human pandemic influenza vaccines in non-vaccine-producing countries

Labelling information of inactivated influenza vaccines for use in pregnant women: Addendum to Annex 3 of WHO Technical Report Series, No. 927

Guidelines on clinical evaluation of vaccines: regulatory expectations

Human Challenge Trials for Vaccine Development: regulatory considerations

Executive Summary. Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC) summary of conclusions and recommendations, Veyrier du Lac, France, 1 – 2 February 2017

Full report. Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC) summary of conclusions and recommendations, Veyrier du Lac, France, 1 – 2 February 2017

Reports of three ad-hoc expert consultations on clinical trials of non-specific effects of vaccines

Presentations

Global Advisory Committee on Vaccine Safety (GACVS) - R. Pless

Immunization Practice Advisory Committee (IPAC) - C. Morgan

Expert Committee on Biological Standardization (ECBS) - K. Cichutek

Immunization and Vaccines related Implementation Research Advisory Committee (IVIR-AC)-R. Breiman

Show less Show more

Session: Global polio eradication initiative

Background documents

Thirteenth Meeting of the SAGE Polio Working Group (WG) WHO, Geneva, February 9-10, 2017, Geneva - notes from the meeting

Should countries continue IPV vaccination in their routine immunization programme after the certification of polio eradication? If so, what is the optimum schedule and for how long should countries continue? Evidence to recommendation table

Grassly NC. Immunogenicity and Effectiveness of Routine Immunization With 1 or 2 Doses of Inactivated Poliovirus Vaccine: Systematic Review and Meta-analysis. The Journal of Infectious Diseases 2014;210(S1):S439–446

Tebbens et al. An economic analysis of poliovirus risk management policy options for 2013–2052. BMC Infectious Diseases (2015) 15:389

Estivariz CF et al. Poliovirus vaccination options for achieving eradication and securing the endgame. Current Opinions in Virology 2013;3:309-315

Presentations

Update of Global Polio Eradication Initiative - M. Zaffran

Updates on IPV supply landscape - D. Chang-Blanc

Report from SAGE Polio Working Group on polio - Y. AL Mazrou

Show less Show more

Session: Use of oral cholera vaccines

Session: Ebola vaccines Update with the development of Ebola vaccines and implications to inform future policy recommendations

Background documents

Update with the development of Ebola vaccines and implications to inform future policy recommendations: prepared by the Ebola Working Group

Henao-Restrepo AM et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffi t!). The Lancet 2017

Presentations

Introduction to the session - F. Were

Overview of Ebola epidemiology - D. Heymann

Update on Ebola candidate vaccines R&D plans, immunogenicity, efficacy and safety and timelines for licensure - A.M. Henao-Restrepo

Observed and forecasted impact of different candidate Ebola vaccines immunization strategies and target populations -A. Camacho

Access to Ebola vaccines before licensure and after licensure - M. Serafini

Conclusions - H. Rees

Show less Show more

Session: National immunization programme management: functions and competencies

Session: Strengthening of National Immunization Technical Advisory Groups (NITAGs)

Background documents

National Immunization Technical Advisory Groups Background Paper

Systematic review on NITAGs

National Immunization Technical Advisory Groups (NITAGs): Guidance for their establishment and strengthening. Vaccine 28S(2010) A18–A25

Adjagba et al. The NITAG Resource Centre (NRC): One-stop shop towards a collaborative platform.  Vaccine 33 (2015)4365–4367

Adjagbaet al. Strengthening and sustainability of National Immunization Technical Advisory Groups (NITAGs) globally: Lessons and recommendations from the founding meeting of the Global NITAG Network

Draft Strategic document of the Global NITAG Network, 20 December 2016

Wijesinghe PR, et al. Participatory decision-making through the Advisory Committee on Communicable Diseases: The Sri Lankan experience. Vaccine 28S (2010) A96–A103

Hall A. The United Kingdom Joint Committee on Vaccination and Immunisation. Vaccine 2010;28S:A54-A57

Senegal NITAG : The "Comité Consultatif pour la Vaccination au Sénégal- CCVS"

Presentations

Progress achieved - L. Dumolard

Successes, issues and challenges in establishing, strengthening and sustainability of NITAGs: United Kingdom - A. Pollard

Successes, issues and challenges in establishing, strengthening and sustainability of NITAGs: Sri Lanka - P. Mahipala

Successes, issues and challenges in establishing, strengthening and sustainability of NITAGs: Senegal - A. Dia Tal

Partners’ support to countries, successes and challenges, lessons learnt and future plans - N. MacDonald

Show less Show more

Session: Private providers engagement with immunization programmes

Background documents

Levin et al. Role of the private sector in the provision of immunization services in low- and middle-income countries

Mitrovich R, et al. A Review of the Private Sector’s Contribution to Immunization Service Delivery in Low, Middle, and High-Income Countries

WHO Guidance Note: Engagement of Private Providers in immunization service delivery. Considerations for National Immunization Programmes

Hagan et al. Knowledge, Attitudes, and Practices of Private Sector Immunization Service Providers in Gujarat, India

Olorunsaiye et al. Missed opportunities and barriers for vaccination: A descriptive analysis of private and public health facilities in four African countries

Amarasinghe A, et al. Report of the survey on private providers’ engagement in immunization in the western Pacific region

Presentations

Introduction to the session, issues and definitions - N. Turner

Systematic review of issues related to the engagement of private providers - M. Watkins

Engagement of private providers with the national Immunization programme: opportunities and challenges. Country experiences: India - S. Zodpey

Engagement of private providers with the national Immunization programme: opportunities and challenges. Country experiences: Uganda - H. Luzze

Proposed recommendations for the engagement of the private sector and steps to facilitate effective relationships to improve immunization coverage and quality services and reduce equity gaps - N. Turner

Show less Show more

Session: Diphtheria